| P50 | author | Mrinal Gounder | Q92508279 |
| | Shadia I. Jalal | Q91794500 |
| P2093 | author name string | Jennifer Hall | |
| | John Kauh | |
| | Patricia M LoRusso | |
| | E Gabriela Chiorean | |
| | Nick Loizos | |
| | Jan Cosaert | |
| | Aejaz Nasir | |
| | Timothy R Holzer | |
| | Valérie André | |
| | Siva Rama Prasad Kambhampati | |
| P2860 | cites work | Cross-talk between the proto-oncogenes Met and Ron | Q22254408 |
| | The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness | Q28201215 |
| | Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential | Q28203075 |
| | The Ron proto-oncogene product is a phenotypic marker of renal oncocytoma | Q28206427 |
| | Multiple pulmonary adenomas in the lung of transgenic mice overexpressing the RON receptor tyrosine kinase. Recepteur d'origine nantais | Q28213995 |
| | Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo | Q28221233 |
| | Multiple pulmonary adenomas in the lung of transgenic mice overexpressing the RON receptor tyrosine kinase | Q29307795 |
| | Tumour-educated macrophages promote tumour progression and metastasis | Q29614307 |
| | The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies | Q29614311 |
| | Smoldering and polarized inflammation in the initiation and promotion of malignant disease | Q29618034 |
| | Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase | Q33703886 |
| | Met-related receptor tyrosine kinase Ron in tumor growth and metastasis. | Q33916081 |
| | Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase | Q35154868 |
| | RON, a tyrosine kinase receptor involved in tumor progression and metastasis | Q36096934 |
| | Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder | Q36615866 |
| | Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets | Q36949153 |
| | Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer | Q39048792 |
| | Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients. | Q40443024 |
| | Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines | Q40841807 |
| | Overexpression of the RON gene in human breast carcinoma | Q41023826 |
| | Macrophage-stimulating protein and its receptor in non-small-cell lung tumors: induction of receptor tyrosine phosphorylation and cell migration | Q41047718 |
| | Cross-talk between the receptor tyrosine kinases Ron and epidermal growth factor receptor | Q42795830 |
| | Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis | Q42824776 |
| | Immunohistochemical analysis of distribution of RON receptor tyrosine kinase in human digestive organs | Q43561410 |
| | Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma | Q44977133 |
| | Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation | Q57100119 |
| | Co-expression and regulation of Met and Ron proto-oncogenes in human hepatocellular carcinoma tissues and cell lines | Q73491986 |
| P433 | issue | 4 | |
| P304 | page(s) | 442-450 | |
| P577 | publication date | 2017-02-04 | |
| P1433 | published in | Investigational New Drugs | Q2312231 |
| P1476 | title | Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors | |
| P478 | volume | 35 | |